BRIEF published on 03/07/2025 at 20:02, 1 year ago EGEIRO Pharma declares bankruptcy after decision of the Board of Directors Bankruptcy TheraVet Reverse Acquisition EGEIRO Pharma Suspension Of Actions
BRIEF published on 09/30/2024 at 07:35, 1 year 5 months ago TheraVet Announces Strategic Shift to Idiopathic Pulmonary Fibrosis Restructuring Phase II TheraVet H4Orphan Pulmonary Fibrosis
PRESS RELEASE published on 09/30/2024 at 07:30, 1 year 5 months ago Inside Information / Operations of the issuer (acquisitions, sales...) TheraVet and H4Orphan collaborate on a strategic project to create a leader in idiopathic pulmonary fibrosis, focusing on innovative treatments. Shareholders to vote on Operation in October 2024 Shareholders Vote Strategic Project TheraVet H4Orphan Idiopathic Pulmonary Fibrosis
PRESS RELEASE published on 09/12/2024 at 07:30, 1 year 6 months ago Inside Information / Other news releases TheraVet announces 2024 half-year results with positive sales growth and reduced operating loss. Company focuses on refinancing options and operational milestones Sales Growth Refinancing Operating Loss 2024 Half-year Results TheraVet
Published on 03/26/2026 at 11:07, 38 minutes ago U.S. Mined and Refined Metals as well as Rare Earth Elements to Be Tokenized in Historic American Strategic Minerals and Datavault AI Deal
Published on 03/26/2026 at 11:00, 45 minutes ago Stagwell Expands the Harris Poll's Harrisquest Across Europe
Published on 03/26/2026 at 08:05, 3 hours 40 minutes ago Vanta Announces U.S. Ticker Symbol Change to VNTXF
Published on 03/26/2026 at 04:55, 6 hours 50 minutes ago Vanta Announces Capital Markets Initiatives to Strengthen Financial Position and Support Growth Initiatives
Published on 03/26/2026 at 11:03, 42 minutes ago EQS-Adhoc: VIDINEXT AG: Marketing agreement with Telekom Deutschland GmbH
Published on 03/26/2026 at 11:00, 45 minutes ago Genel Energy PLC: Posting of Annual Report and Notice of AGM
Published on 03/26/2026 at 11:00, 45 minutes ago Genel Energy PLC: Report on payments to governments for the year 2025
Published on 03/26/2026 at 11:00, 45 minutes ago ABB Ltd: ABB share buybacks - March 19, 2026 - March 25, 2026
Published on 03/26/2026 at 11:00, 45 minutes ago Independent study reveals 44% ROI with EQS Compliance Cockpit and payback in under six months
Published on 03/26/2026 at 07:30, 4 hours 15 minutes ago BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
Published on 03/25/2026 at 18:31, 17 hours 14 minutes ago Strong investment performance and active roll-out of our strategy
Published on 03/25/2026 at 17:45, 18 hours ago Combined General Meeting on May 05, 2026: publication of the notice of Meeting
